After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as "available" on the U.S. Food and Drug Administration's drug shortage list.

The Federal Drug Administration has approved the rebranding of a diabetes drug to help manage weight loss. This comes after the increase in popularity of Wegovy and Ozempic over the last year.

Celebrities have long been guilty of glamorizing extreme weight-loss fads, but the recent popularization of prescription Ozempic is normalizing medical intervention in the pursuit of thinness.

A new study has found that users of Ozempic or a similar drug had a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than those without a prescription. Fernanda ...

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Some doctors, along with the U.S. Food and Drug ...

With a cheeky rebrand, Goldfish takes aim at adult snackers ... as GLP-1 drugs that curb hunger, like Ozempic, continue to climb in popularity. While the snacking market has yet to document ...

Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA-approved for this use. Both drugs are approved for ...

Ozempic (semaglutide) is a GLP-1 RA (glucagon-like peptide-1 receptor agonist), also known as a “GLP-1” drug. It’s an effective medication for managing type 2 diabetes and for weight loss.

Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic and ...

NEW YORK — On Tuesday evening in a Brooklyn warehouse lit with a pink cast, the Victoria’s Secret Fashion Show was back.

The conversation also involved the company's shift from diet culture and its rebrand as a weight-health company. Weight loss drugs like Ozempic and Wegovy were discussed as a medical intervention ...

But —” [LAUGHS] [MUSIC PLAYING] “To start, I’ve seen you online or in other interviews talk about the idea that you’re kind of in the middle of a rebranding. But the thing that I haven ...